4th Quarter - Report

PORTERFIELD, FETTIG & SEARS, LLC for ASTELLAS PHARMA US, INC.

Firm
Client
Income
$50,000
Expenses
—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Issues related to P.L. 96-517, the Bayh-Dole Act; issues related to drug pricing.

Foreign entity interest: Astellas Pharma, Inc. based in Tokyo, Japan and as identified in our Lobbying Registration has an interest as a pharmaceutical company in all of the issues with respect to which Astellas Pharma US has advocated and listed herein.

LobbyistCovered position, as disclosed
JEREMY RABINOVITZ —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.